Articles dans des revues avec comité de lecture (59)
  1. 1. Ando, K., Kosa, A.-C., Mehadji, Y., Lasri, H., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Doeraene, E., Wathelet-Depauw, A., Nagaraj, S., Brion, J. P., & Leroy, K. (2025). Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model. Biomolecules, 15(2), doi.org/10.3390/biom15020159, 159.
  2. 2. Nagaraj, S., Quintanilla Sanchez, C., Ando, K., López Gutiérrez, L., Doeraene, E., Kosa, A.-C., Aydin, E., Brion, J. P., & Leroy, K. (2024). Downregulation of hsa-miR-132 and has-miR129: non-coding RNA molecular signatures of Alzheimer's disease. Frontiers in Molecular Neuroscience, 17(2), 10.3389/fnmol.2024.1423340.
  3. 3. Ando, K., Küçükali, F., Doeraene, E., Nagaraj, S., Antonelli, E. M., Htut Thazin, M., Yilmaz, Z., Kosa, A.-C., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Ramos, A. R., Mansour, S., Turbant, S., Schurmans, S., Sleegers, K., Erneux, C., Brion, J. P., & Leroy, K. (2024). Alteration of gene expression and protein solubility of the PI5- phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression. Acta Neuropathologica, 147(94), 10.1007/s00401-024-02745-7.
  4. 4. Ehongo Bidime, A., Dugauquier, A., Kisma, N., De Maertelaer, V., Nana Wandji, B., Tchatchou Tomy, W., Alaoui Mhammedi, Y., Coppens, K., Leroy, K., & Bremer, F. (2023). Myopic (Peri)papillary Changes and Visual Field Defects. Clinical Ophthalmology (Print), 17, 3295-3306. doi:10.2147/OPTH.S404167
  5. 5. Ehongo Bidime, A., Hasnaoui, Z., Kisma, N., Alaoui Mhammedi, Y., Dugauquier, A., Coppens, K., Wellens, E., De Maertelaer, V., Bremer, F., & Leroy, K. (2023). Peripapillary intrachoroidal cavitation at the crossroads of peripapillary myopic changes. International journal of ophthalmology, 16(12), 2063-2070. doi:10.18240/ijo.2023.12.20
  6. 6. Ando, K., Nagaraj, S., Küçükali, F., De Fisenne, M.-A., Kosa, A.-C., Doeraene, E., López Gutiérrez, L., Brion, J. P., & Leroy, K. (2022). PICALM and Alzheimer’s Disease: An Update and Perspectives. Cells, 11(24), 3994. doi:10.3390/cells11243994
  7. 7. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in male mouse models. Neurobiology of disease, 174, 105875. doi:10.1016/j.nbd.2022.105875
  8. 8. Ehongo Bidime, A., Bacq, N., Kisma, N., Dugauquier, A., Alaoui Mhammedi, Y., Coppens, K., Bremer, F., & Leroy, K. (2022). Analysis of Peripapillary Intrachoroidal Cavitation and Myopic Peripapillary Distortions in Polar Regions by Optical Coherence Tomography. Clinical Ophthalmology (Print), Volume 16, 2617-2629. doi:10.2147/OPTH.S376597
  9. 9. Chivasso, C., Nesverova, V., Jarva, M., Blanchard, A., Rose, K. L., Oberg, K., Wang, Z., Martin, M., Lhotellerie, F., Zindy, E., Junqueira, B., Leroy, K., Vanhollebeke, B., Delforge, V., Bolaky, N., Perret, J., Soyfoo, M. S., Moscato, S., Baldini, C., Chaumont, F., Mattii, L., Schey, K. L., Myal, Y., Törnroth-Horsefield, S., & Delporte, C. (2021). Unraveling Human AQP5-PIP Molecular Interaction and Effect on AQP5 Salivary Glands Localization in SS Patients. Cells, 10, 2108. doi:10.3390/cells10082108
  10. 10. Sáez-Orellana, F., Leroy, T., Ribeiro, F., Kreisler, A., Leroy, K., Lalloyer, F., Baugé, E., Staels, B., Duyckaerts, C., Brion, J. P., Gailly, P., Octave, J. N., & Pierrot, N. (2021). Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity. JCI insight, 6(16). doi:10.1172/jci.insight.150099
  11. 11. Ando, K., Erneux, C., Homa, M., Houben, S., De Fisenne, M.-A., Brion, J. P., & Leroy, K. (2021). Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease. Frontiers in Neuroscience, 15, 614855. doi:10.3389/fnins.2021.614855
  12. 12. Houben, S., Homa, M., Yilmaz, Z., Leroy, K., Brion, J. P., & Ando, K. (2021). Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us? Frontiers in neurology, 12, 610330. doi:10.3389/fneur.2021.610330
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 Suivant >>